The Wnt Signaling Pathway and Related Therapeutic Drugs in Autism Spectrum Disorder
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Bae, Seung Min | - |
dc.contributor.author | Hong, Ji Yeon | - |
dc.date.available | 2020-02-27T10:42:43Z | - |
dc.date.created | 2020-02-07 | - |
dc.date.issued | 2018-05 | - |
dc.identifier.issn | 1738-1088 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/3805 | - |
dc.description.abstract | Autism spectrum disorder (ASD) is a series of neurodevelopmental disorder with a large genetic component. However, the pathogenic genes and molecular mechanisms of ASD have not been clearly defined. Recent technological advancements, such as next-generation sequencing, have led to the identification of certain loci that is responsible for the pathophysiology of ASD. Three functional pathways, such as chromatin remodeling, Wnt signaling and mitochondrial dysfunction are potentially involved in ASD. In this review, we will focus on recent studies of the involvement of Wnt signaling pathway components in ASD pathophysiology and related drugs used in ASD treatment. | - |
dc.language | 영어 | - |
dc.language.iso | en | - |
dc.publisher | KOREAN COLL NEUROPSYCHOPHARMACOLOGY | - |
dc.relation.isPartOf | CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE | - |
dc.subject | HOMEOBOX-TRANSCRIPTION-FACTOR | - |
dc.subject | GENE | - |
dc.subject | CLOZAPINE | - |
dc.subject | HALOPERIDOL | - |
dc.subject | ASSOCIATION | - |
dc.subject | ENGRAILED-2 | - |
dc.subject | ACTIVATION | - |
dc.subject | MUTATIONS | - |
dc.subject | DELETION | - |
dc.subject | TARGETS | - |
dc.title | The Wnt Signaling Pathway and Related Therapeutic Drugs in Autism Spectrum Disorder | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 1 | - |
dc.identifier.wosid | 000432990900001 | - |
dc.identifier.doi | 10.9758/cpn.2018.16.2.129 | - |
dc.identifier.bibliographicCitation | CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE, v.16, no.2, pp.129 - 135 | - |
dc.identifier.kciid | ART002351493 | - |
dc.identifier.scopusid | 2-s2.0-85047081595 | - |
dc.citation.endPage | 135 | - |
dc.citation.startPage | 129 | - |
dc.citation.title | CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE | - |
dc.citation.volume | 16 | - |
dc.citation.number | 2 | - |
dc.contributor.affiliatedAuthor | Bae, Seung Min | - |
dc.type.docType | Review | - |
dc.subject.keywordAuthor | Autism spectrum disorder | - |
dc.subject.keywordAuthor | Wnt | - |
dc.subject.keywordAuthor | Beta-catenin | - |
dc.subject.keywordAuthor | Chromodomain helicase DNA binding protein 8 | - |
dc.subject.keywordAuthor | Neuronal development | - |
dc.subject.keywordPlus | HOMEOBOX-TRANSCRIPTION-FACTOR | - |
dc.subject.keywordPlus | GENE | - |
dc.subject.keywordPlus | CLOZAPINE | - |
dc.subject.keywordPlus | HALOPERIDOL | - |
dc.subject.keywordPlus | ASSOCIATION | - |
dc.subject.keywordPlus | ENGRAILED-2 | - |
dc.subject.keywordPlus | ACTIVATION | - |
dc.subject.keywordPlus | MUTATIONS | - |
dc.subject.keywordPlus | DELETION | - |
dc.subject.keywordPlus | TARGETS | - |
dc.relation.journalResearchArea | Neurosciences & Neurology | - |
dc.relation.journalResearchArea | Pharmacology & Pharmacy | - |
dc.relation.journalWebOfScienceCategory | Neurosciences | - |
dc.relation.journalWebOfScienceCategory | Pharmacology & Pharmacy | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.